Evidence that the autoimmune antigen myelin basic protein (MBP) Ac1-9 binds towards one end of the major histocompatibility complex (MHC) cleft

Journal of Experimental Medicine

Volumn 187, Issue 9, 1998, Pages 1505-1516

  Lee, Christopher ^a   Liang, Michael N ^a   Tate, Keri M ^a   Rabinowitz, Joshua D ^a   Beeson, Craig ^a   Jones, Patricia P ^a   McConnell, Harden M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IA ANTIGEN; MYELIN BASIC PROTEIN;

AMINO TERMINAL SEQUENCE; ANTIGEN BINDING; ARTICLE; HUMAN; HUMAN CELL; L CELL; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; IMMUNE TOLERANCE; KINETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; MUTAGENESIS, SITE-DIRECTED; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; PROTEIN BINDING;

EID: 0032482175     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.9.1505     Document Type: Article

References (59)

1. Stern, L.J., and D.C. Wiley. 1994. Antigenic peptide binding by class I and class II histocompatibility proteins. Structure. 2:245-251.
2. Stern, L.J., J.H. Brown, T.J. Jardetzky, J.C. Gorga, R.G. Urban, J.L. Strominger, and D.C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 368:215-221.
3. Ghosh, P., M. Amaya, E. Mellins, and D.C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature. 378:457-462.
4. Fremont, D.H., W.A. Hendrickson, P. Marrack, and J. Kappler. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science. 272:1001-1004.
5. Jardetzky, T.S., J.H. Brown, J.C. Gorga, L.J. Stern, R.G. Urban, J.L. Strominger, and D.C. Wiley. 1996. Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polypropylene II-like conformation for bound peptides. Proc. Natl. Acad. Sci. USA. 93:734-738.
6. Nelson, C.A., S.J. Petzold, and E.R. Unanue. 1994. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature. 371:250-252.
7. Bertoletti, A., A. Sette, F.V. Chisari, A. Penna, M. Levrero, M. De Carli, F. Fiaccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature. 369:407-410.
8. Beeson, C., J. Rabinowitz, K. Tate, I. Gutgemann, Y.-H. Chien, P.P. Jones, M.M. Davis, and H.M. McConnell. 1996. Early biochemical signals arise from low affinity TCR-ligand reactions at the cell-cell interface. J. Exp. Med. 184:777-782.
9. Fairchild, P.J., R. Wildgoose, E. Atherton, S. Webb, and D.C. Wraith. 1993. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int. Immunol. 5:1151-1158.
10. Joosten, I., M.H.M. Wauben, M.C. Holewijn, K. Reske, L.O. Pederson, C.F.P. Roosenboom, E.J. Hensen, W. van Eden, and S. Buus. 1994. Direct binding of autoimmune disease related T cell epitopes to purified Lewis rat MHC class II molecules. Int. Immunol. 6:751-759.
11. Kumar, V., V. Bhardwaj, L. Soares, J. Alexander, A. Sette, and E. Sercarz. 1995. Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential selection of interleukin 4/5 or interferon γ by T cells. Proc. Natl. Acad. Sci. USA. 92:9510-9514.
12. Liu, G.Y., P.J. Fairchild, R.M. Smith, J.R. Prowie, D. Kioussis, and D.C. Wraith. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity. 3:407-415.
13. Fairchild, P.J., and D.C. Wraith. 1996. Lowering the tone: mechanisms of immunodominance among epitopes with low affinity for MHC. Immunol. Today. 17:80-85.
14. Rothbard, J.B., and M.L. Gefter. 1991. Interactions between immunogenic peptides and MHC proteins. Annu. Rev. Immunol. 9:527-565.
15. k form and dissociate rapidly at neutral pH. J. Immunol. 154:5216-5227.
16. u. Biochemistry. 34:14874-14878.
17. Wraith, D.C., D.E. Smilek, D.J. Mitchell, L. Steinman, and H.O. McDevitt. 1989. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell. 59:247-255.
18. Smilek, D.E., D.C. Wraith, S. Hodgkinson, S. Dwivedy, L. Steinman, and H.O. McDevitt. 1991. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA. 88:9633-9637.
19. Gautam, A.M., C.I. Pearson, D.E. Smilek, L. Steinman, and H.O. McDevitt. 1992. A polyalanine peptide with only five native myelin basic protein residues induces autoimmune encephalomyelitis. J. Exp. Med. 176:605-609.
20. Wraith, D.C., B. Bruun, and P.J. Fairchild. 1992. Cross-reactive antigen recognition by an encephalitogenic T cell receptor. Implications for T cell biology and autoimmunity. J. Immunol. 149:3765-3770.
21. Gautam, A.M., C.B. Lock, D.E. Smilek, C.I. Pearson, L. Steinman, and H.O. McDevitt. 1994. Minimum structural requirements for peptide presentation by major histocumpatibility complex class II molecules: implications in induction of autoimmunity. Proc. Natl. Acad. Sci. USA. 91:767-771.
22. Gautam, A.M., C. Pearson, V. Quinn, H.O. McDevitt, and P.J. Milburn. 1995. Binding of an invariant-chain peptide, CLIP, to I-A major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA. 92:335-339.
23. Tate, K.M., C. Lee, S. Edelman, C. Carswell-Crumpton, R. Liblau, and P.P. Jones. 1995. Interactions among polymorphic and conserved residues in MHC class II proteins affect MHC:peptide conformation and T cell recognition. Int. Immunol. 7:747-761.
24. d. Proc. Natl. Acad. Sci. USA. 81:7564-7568.
25. Busch, K., G. Strang, K. Howland, and J. Rothbard. 1990. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. Int. Immunol. 2:443-451.
26. Oi, V.T., P.P. Jones, L.A. Herzenberg, and L.A. Herzenberg. 1978. Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. Currr. Top. Microbiol. Immunol. 81:115-129.
27. Witt, S.N., and H.M. McConnell. 1991. A first-order reaction controls the binding of antigenic peptides to major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA. 88:8164-8168.
28. Rabinowitz, J.D., K. Tate, C. Lee, C. Beeson, and H.M. McConnell. 1997. Specific T cell recognition of kinetic isomers in the binding of peptide to class II major histocompatibility complex. Proc. Natl. Acad. Sci. USA. 94:8702-8707.
29. Brown, J.H., T.S. Jardetzky, J.C. Gorga, L.J. Stern, R.G. Urban, J.L. Strominger, and D.C. Wiley. 1993. The three-dimensional structure of the human class H histocompatibility antigen HLA-DR1. Nature. 364:33-39.
30. Lee, C., and S. Subbiah. 1991. Prediction of protein side-chain conformation by packing optimization. J. Mol. Biol. 217:373-388.
31. Lee, C. 1994. Predicting protein mutant energetics by self-consistent ensemble optimization. J. Mol. Biol. 236:918-939.
32. Lee, C., and H.M. McConnell. 1995. A general model of invariant chain association with class II major histocompatibility complex proteins. Proc. Natl. Acad. Sci. USA. 92:8269-8273.
33. Levitt, M. 1992. Accurate modeling of protein conformation by automatic segment matching. J. Mol. Biol. 226:507-533.
34. Levitt, M. 1983. Molecular dynamics of native protein: computer simulation of trajectories. J Mol. Biol. 168:595-620.
35. Deleted in proof.
36. Liang, M.N., C. Lee, Y. Xia, and H.M. McConnell. 1996. Molecular modeling and design of invariant chain peptides with altered dissociation kinetics from class II MHC. Biochemistry. 35:14734-14742.
37. Dougherty, D.A. 1996. Cation-π interactions in chemistry and biology: a new view of benzene, Phe, Tyr and Trp. Science. 271:163-168.
38. Stites, W.E., A.G. Gittis, E.E. Lattman, and D. Shortle. 1991. In a staphylococcal nuclease mutant the side-chain of a lysine replacing valine 66 is fully buried in the hydrophobic core. J. Mol. Biol. 221:7-14.
39. Pearson, C.I. 1994. An analysis of peptide, MHC, and T cell receptor trimolecular complexes in experimental autoimmune encephalomyelitis (encephalomyelitis). Ph.D. thesis. Stanford University, Stanford, CA. 144 pp.
40. Davis, C.B., D.J. Mitchell, D.C. Wraith, J.A. Todd, S.S. Zamvil, H.O. McDevitt, L. Steinman, and P.P. Jones. 1989. Polymorphic residues on the I-Aβ chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic protein. J. Immunol. 143:2083-2093.
41. Mason, K. 1995. Interactions of antigenic peptides with class II major histocompatibility molecules. Ph.D. thesis. Stanford University, Stanford, CA. 102 pp.
42. Busch, R., C.M. Hill, J.D. Hayball, J.R. Lamb, and J.B. Rothbard. 1991. Effect of natural polymorphism at residue 86 of the HLA-DR β chain on peptide binding. J. Immunol. 147:1292-1298.
43. Demotz, S., C. Barbey, G. Corradin, A. Amoroso, and A. Lanzavecchia. 1993. The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86. Eur. J. Immunol. 23:425-432.
44. Newton-Nash, D.K., and D.D. Eckels. 1993. Differential effect of polymorphism at HLA-DR1 β-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides. J. Immunol. 150:1813-1821.
45. Deleted in proof.
46. Gulden, P.H., P.I. Fischer, V.H. Engelhard, J. Shabanowitz, D.F. Hunt, and E.G. Pamer. 1996. A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule. Immunity. 5:73-79.
47. Lenz, L.L., B. Dere, and M.J. Bevan. 1996. Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3. Immunity. 5:63-72.
48. Lindahl, K.F., D.E. Byers, V.M. Dabhi, R. Hovik, E.P. Jones, G.P. Smith, C.R. Wang, H. Xiao, and M. Yoshino, 1997. H2-M3, a full-service class Ib histocompatibility antigen. Annu. Rev. Immunol. 15:851-879.
49. d. FEBS Lett. 294:244-246.
50. Alam, S.M., P.J. Travers, J.L. Wung, W. Nasholds, S. Redpath, S.C. Jameson, and N.R.J. Gascoigne. 1996. T-cell-receptor affinity and thymocyte positive selection. Nature. 381:616-620.
51. Lyons, D.S., S.A. Lieberman, J. Hampl, J.J. Boniface, Y. Chien, L.J. Berg, and M.M. Davis. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity. 5:53-61.
52. Garcia, K.C., M. Degano, R.L. Stanfield, A. Brunmark, M.R. Jackson, P.A. Peterson, L. Teyton, and I.A. Wilson. 1996. An αβ T cell receptor structure at 2.5 A and its orientation in the TCR-MHC. complex. Science. 274:209-219.
53. Pribyl, T.M., C.W. Campagnoni, K. Kampf, T. Kashima, V.W. Handley, J. McMahon, and A.T. Campagnoni. 1993. The human myelin basic protein gene is included within a 179-kilobase transcription unit: expression in the immune and central nervous systems. Proc. Natl. Acad. Sci. USA. 90:10695-10699.
54. Fritz, R.B., and I. Kalvakolanu. 1995. Thymic expression of the golli-myelin basic protein gene in the SJL/J mouse. J. Neuroimmunol. 57:93-99.
55. Landry, C.F., J.A. Ellison, T.M. Pribyl, C. Campagnoni, K. Kampf, and A.T. Campagnoni. 1996. Myelin basic protein gene expression in neurons: developmental and regional changes in protein targeting within neuronal nuclei, cell bodies, and processes. J. Neurosci. 16:2452-2462.
56. Evavold, B.D., and P.M. Allen. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science. 252:1308-1310.
57. Racioppi, L., F. Ronchese, L.A. Matis, and R.N. Germain. 1993. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177:1047-1060.
58. Kersh, G.J., and P.M. Allen. 1996. Essential flexibility in the T-cell recognition of antigen. Nature. 380:495-498.
59. Margulies, D.H. 1996. An affinity for learning. Nature. 381:558-559.